Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for heart rate reduction in sepsis syndromes
PACTR201510001274643Recruiting
- Sponsor
- anesthesia and ICU departement , faculty of medicine, Cairo univ
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ivabradine in sepsis, septic shock and multiple organ dysfunction syndrome (MODS) (3 arms), sponsored by anesthesia and ICU departement , faculty of medicine, Cairo univ. Primary endpoint: Reduction in baseline heart rate. Started Oct 2015; status: recruiting.
02
Drugs
ivabradine
03
Conditions
sepsisseptic shockmultiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on PACTR201510001274643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201510001274643.